Neisseria meningitidis serogroups A and W-135: Carriage and immunity in Burkina Faso, 2003

Journal of Infectious Diseases

Volumn 193, Issue 6, 2006, Pages 812-820

  Mueller, Judith E ^a,g   Yaro, Seydou ^b   Traoré, Yves ^a,e   Sangaré, Lassana ^c   Tarnagda, Zekiba ^b,f   Njanpop Lafourcade, Berthe Marie ^a   Borrow, Raymond ^d   Gessner, Bradford D ^a  

^a Agence de Medecine Preventive   (France)

^b CENTRE MURAZ   (Burkina Faso)

^c CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^f Centre National de la Recherche Scientifique et Technologique   (Burkina Faso)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; POLYSACCHARIDE VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD GROUP TYPING; BLOOD SAMPLING; BURKINA FASO; FEMALE; HUMAN; IMMUNITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; STRAIN DIFFERENCE; VACCINATION;

ADOLESCENT; ADULT; BURKINA FASO; CARRIER STATE; CHILD; CHILD, PRESCHOOL; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS, SEROGROUP A; NEISSERIA MENINGITIDIS, SEROGROUP W-135; OROPHARYNX;

EID: 33644890713     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500511     Document Type: Article

References (35)

1. World Health Organization, Geneva. Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rec 2005; 80:313-20.
2. Kwara A, Adegbola RA, Corrah PT, et al. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health 1998; 3:742-6.
3. Taha MK, Parent du Châtelet I, Schlumberger M, et al. Neisseria meningitidis serogroups S135 and A were equally prevalent among meningitis cases occurring at the end of 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 2002; 40:1083-4.
4. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report, 2002. Wkly Epidemiol Rec 2002; 77:152-5.
5. Al-Mazrou Y, Khalil M, Borrow R, et al. Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. Infect Immun 2005; 73:2932-9.
6. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129:1327-48.
7. Reller LB, MacGregor RR, Beaty HN. Bacterial antibody after colonization with Neisseria meningitidis. J Infect Dis 1973; 127:56-62.
8. Brooks GF, Lammel CJ, Blake MS, Kusecek B, Achtman M. Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis. J Infect Dis 1992; 166:1316-21.
9. Kriz P, Kriz B, Svandova E, Musilek M. Antimeningococcal herd immunity in the Czech Republic-influence of an emerging clone, Neisseria meningitidis ET-15/37. Epidemiol Infect 1999; 123:193-200.
10. Maiden MCJ, Stuart JM, UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002; 359:1829-30.
11. Parent du Châtelet I, Traoré Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 2005; 40:17-25.
12. World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO Communicable Disease Surveillance and Response. WHO/CDS/CSR/EDC/99.7. Geneva: World Health Organization, 1999.
13. Njanpop-Lafourcade B-M, Traoré Y, Aguilera JF, et al. Contribution de la PCR à la surveillance microbiologique et épidé miologique des méningites bactériennes aiguës en Afrique: à propose de l'expérience d'un transfert de technologie réussi au Centre Muraz de Bobo-Dioulasso, Burkina Faso. Revue Française des Laboratoires 2005; 372:33-40.
14. Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000; 38:855-7.
15. Deghmane AE, Giogini D, Larribe M, Alonso JM, Taha MK. Down regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol 2002; 43:1555-64.
16. Lal G, Balmer P, Joseph H, Dawson M, Borrow R. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W135. Clin Diagn Lab Immunol 2004; 11:272-9.
17. Holder PK, Maslanka SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference. Clin Diagn Lab Immunol 1995; 2:132-7.
18. Joseph H, Balmer P, Bybel M, Papa T, Ryall R, Borrow R. Assignment of Neisseria meningitidis serogroup A, C, W135 and Y anticapsular total IgG, IgG1 and IgG2 concentrations to reference sera. Clin Diagn Lab Immunol 2004; 11:1-5.
19. Maslanka SE, Gheesling LL, LiButti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin Diagn Lab Immunol 1997; 4:156-67.
20. Balmer P, Borrow R. Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev Vaccines 2004; 3:89-99.
21. Andrews N, Borrow R, Miller E. Validation of serological correlate of protection for meningococcal C conjugated vaccine using efficacy estimates from post-licensure surveillance in England. Clin Diagn Lab Immunol 2003; 10:780-6.
22. Blakebrough IS, Greenwood BM, Whittle HC, Bradley AK, Gilles HM. The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis 1982; 146:626-37.
23. Amir J, Louie L, Granoff DM. Naturally-acquired immunity to Neisseria meningitidis group A. Vaccine 2005; 23:977-83.
24. Holten E, Vaage L, Jyssum K. Bactericidal activity in sera from carriers of sulphonamide-resistant meningococci. Scand J Infect Dis 1970; 2:201-4.
25. Griffiss JM, Brandt BL, Altieri PL, Pier GB, Berman SL. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun 1981; 34:725-32.
26. Lepow ML, Beeler J, Randolph M, Samuelson JS, Hankins WA. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children. J Infect Dis 1986; 154:1033-6.
27. Granoff DM, Morgan A, Welsch JA. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children. Vaccine 2005; 23:4307-14.
28. Giesecke J. Modern infectious disease epidemiology. 2nd ed. London: Arnold, 2002.
29. Sim RJ, Harrison MM, Moxon ER, Tang CM. Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. Lancet 2000; 356:1653-4.
30. Vann WF, Liu TY, Robbins JB. Bacillus pumilus polysaccharide crossreactive with meningococcal group A polysaccharide. Infect Immun 1976; 13:1654-62.
31. Guirguis N, Schneerson R, Bax A, et al. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis: immunochemical, biological, and epidemiological studies. J Exp Med 1985; 162:1837-51.
32. MacLennan JM, Urwin R, Obaro S, Griffiths D, Greenwood B, Maiden MCJ. Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? Lancet 2000; 356:1078.
33. Blakebrough IS, Greenwood BM, Whittle HC, Bradley AK, Gilles HM. Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. Ann Trop Med Parasitol 1983; 77: 175-8.
34. Moore PS, Harrison LH, Telzak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA 1988; 260:2686-9.
35. Hassan-King MKA, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect 1988; 16:55-9.